* Japanese*
Hokkaido University , Faculty of Science
2002.03 , Graduated
Hokkaido University , Graduate School, Division of Natural Science
Doctor Course , 2007.03 , Completed
English: Kono M, Wakisaka R, Komatsuda H, Hayashi R, Kumai T, Yamaki H, Sato R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Kobayashi H, Hayashi T, Takahara M., Immunotherapy targeting tumor-associated antigen in a mouse model of head and neck cancer , Head Neck , 2024
English: Nagato T, Komatsuda H, Hayashi R, Takahara M, Ujiie N, Kosaka A, Ohkuri T, Oikawa K, Sato R, Wakisaka R, Kono M, Yamaki H, Ohara K, Kumai T, Kishibe K, Katada A, Hayashi T, Kobayashi H., Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma , Cancer Science , 2024
English: Murai A, Kubo T, Ohkuri T, Yanagawa J, Yajima Y, Kosaka A, Li D, Nagato T, Murata K, Kanaseki T, Tsukahara T, Nagasaki T, Hirohashi Y, Kobayashi H, Torigoe T., NF9 peptide specific cytotoxic T lymphocyte clone cross react to Y453F mutation of SARS-CoV-2 virus spike protein , Immunological Medicine , 2024
English: Yajima Y, Kosaka A, Ohkuri T, Hirohashi Y, Li D, Nagasaki T, Nagato T, Torigoe T, Kobayashi H., SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity , Heliyon , vol.9 (9) (p.e20192 - ) , 2023
English: Yamaki H, Kono M, Wakisaka R, Komatsuda H, Kumai T, Hayashi R, Sato R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Hayashi T, Kobayashi H, Katada A., Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer , Cancer Immunology, Immunotherapy , 2023
Partner division:Private Enterprise , 2016.05 - 2019.05
2016year , Partaker , 5,443,600yen
2017year , Partaker , 0yen
2018year , Partaker , 5,395,000yen
2019year , Partaker , 0yen
Updated on 2024/04/01
Copyright (C) 2012~ Asahikawa Medical University, All Rights Reserved.